Zimmer Biomet Holdings, Inc. (ZBH)

Zimmer Biomet Holdings, Inc. (ZBH) is a healthcare company (medical devices) based in the United States. The share price is $103.92, up 2.47% on the day, which values the company at $19.67B. Price as of 17 Nov 2026, 17:35 UTC, from Yahoo Finance.

Key facts

Share price
$103.92+2.47% today
Market value
$19.67B
P/E ratio
26.2×last 12 months
Forward P/E
11.6×
Dividend yield
0.95%
Funk Score
52/100
Against its own history
Below its usual priceusual price $128.21
200-week average
$108.104% below

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Zimmer Biomet Holdings, Inc. in more detail

ZBH trades at 26.2× its last twelve months' earnings, 11.6× next year's expected earnings, 2.3× sales. Measured against its own history, the price is 19% below what its usual multiples would imply ($128.21) — below its usual price. It sits 4% below its 200-week average of $108.10.

Over the last five fiscal years Zimmer Biomet Holdings, Inc. has compounded revenue 6.1% a year, free cash flow 5.4% a year. Its Funk Score is 52 out of 100 (financial strength 3.5, profitability 6.2, growth 5.3, value 6.0, each out of 10).

In its favour: Share count keeps falling; Five straight years of revenue growth.

10 of the superinvestors tracked here hold ZBH, including Harry Burn (2.2% of the portfolio), Bill Nygren (1.5% of the portfolio), Dodge & Cox team (1.1% of the portfolio).

Superinvestors holding ZBH

10 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:ZBH vs ALNY (Zimmer Biomet Holdings, Inc. vs Alnylam Pharmaceuticals)ZBH vs GH (Zimmer Biomet Holdings, Inc. vs Guardant Health)ZBH vs BNTX (Zimmer Biomet Holdings, Inc. vs BioNTech)ZBH vs MEDP (Zimmer Biomet Holdings, Inc. vs Medpace Holdings)ZBH vs THC (Zimmer Biomet Holdings, Inc. vs Tenet Healthcare)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

Zimmer Biomet Holdings, Inc. (ZBH): questions and answers

What is ZBH's P/E ratio?

Zimmer Biomet Holdings, Inc. trades at 26.2× its last twelve months' earnings and 11.6× next year's expected earnings. At its fiscal year-ends over the past 17 years the P/E ranged from 10.9× to 133.2×, with a median of 23.8×.

What is ZBH's PEG ratio?

Zimmer Biomet Holdings, Inc.'s PEG ratio is 2.21 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Zimmer Biomet Holdings, Inc.'s market cap?

Zimmer Biomet Holdings, Inc. is valued at $19.67B at a share price of $103.92.

Is ZBH overvalued or undervalued?

Against its own history, ZBH is below its usual price: the price is 19% below the $128.21 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is ZBH above its 200-week moving average?

No. ZBH is 3.9% below its 200-week average of $108.10. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Zimmer Biomet Holdings, Inc. growing?

Over the last five fiscal years Zimmer Biomet Holdings, Inc.'s revenue grew 6.1% a year; over ten years revenue grew 3.2% a year.

Cite this page

Funkfolio, “Zimmer Biomet Holdings, Inc. (ZBH) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ZBH

Underlying data: Yahoo Finance; company filings with the SEC.